Pharma News, 2016

Advisors to the European Medicines Agency (EMA) are backing approval of Janssen's Stelara, bringing the drug closer to becoming the first interleukin (IL)-12/23 inhibitor licensed ...

GSK today announces that Emma Walmsley, currently Chief Executive Officer (CEO) of GSK’s Consumer Healthcare division, is appointed GSK CEO Designate and will succeed Andrew Witty as GSK CEO...

The U.

Allergan PLC on Tuesday said it agreed to acquire Tobira Therapeutics Inc.

Johnson & Johnson announced Friday that it has offered Abbott Laboratories $4.

Munich, Germany, 16 September 2016 - Novo Nordisk today announced that semaglutide, an investigational glucagon-like peptide-1 (GLP-1) analogue administered once-weekly, significantly reduced ...

 Eleven new medicines have taken a giant leap closer to European Union approval after having won the backing of the Committee for Medicinal Products for Human Use.

The US Department of Health and Human Services (HHS) has issued a final rule that specifies requirements for registering certain clinical trials and submitting summary results information.

When it comes to controlling blood sugar in Type 2 diabetes patients, two drug classes may be better than one, AstraZeneca ($AZN) said Friday.

(CNN) -- Health Canada has amended its regulations to allow Canadian doctors to prescribe heroin as a treatment for those who are severely addicted to the drug.

MISSISSAUGA, Canada I September 15, 2016 I Aralez Pharmaceuticals Inc.

Melbourne.